Hobin Yang

Busan, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Proteomic Profiling Identifies CLDN3 as a Tumor-Selective Therapeutic Target in Small Cell Lung Cancer.

Journal: bioRxiv : the preprint server for biology

Published: August 20, 2026

Phage Display Technology: Design, Library Construction, and Panning Strategies for Antibody Development.

Phage Display Technology: Design, Library Construction, and Panning Strategies for Antibody Development.

Journal: Biomolecules & therapeutics

Published: August 19, 2025

Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer.

Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer.

Journal: Translational oncology

Published: May 15, 2024

Design, Screening and Development of Asymmetric siRNAs Targeting the MYC Oncogene in Triple-Negative Breast Cancer.

Design, Screening and Development of Asymmetric siRNAs Targeting the MYC Oncogene in Triple-Negative Breast Cancer.

Journal: Biomolecules & therapeutics

Published: May 04, 2024

Translation Initiation Factor-2S2 (eIF2S2) Contributes to Cervical Carcinogenesis by Inhibiting the TGF-β/SMAD4 Signaling Pathway.

Translation Initiation Factor-2S2 (eIF2S2) Contributes to Cervical Carcinogenesis by Inhibiting the TGF-β/SMAD4 Signaling Pathway.

Journal: Biomolecules & therapeutics

Published: January 30, 2024

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.

Journal: Cancer research and treatment

Published: July 01, 2022

Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.

Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.

Journal: Frontiers in oncology

Published: February 21, 2022

Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer.

Visualization of a novel human monoclonal antibody against Claudin-3 for targeting ovarian cancer.

Journal: Nuclear medicine and biology

Published: December 18, 2021

Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse.

Relevance of Circulating Tumor Cells as Predictive Markers for Cancer Incidence and Relapse.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 06, 2021

Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma.

Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma.

Journal: Cancer research and treatment

Published: July 25, 2021

Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH.

Macrosphelide A Exhibits a Specific Anti-Cancer Effect by Simultaneously Inactivating ENO1, ALDOA, and FH.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 05, 2021

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling.

Matrix metalloproteinase 11 (MMP11) in macrophages promotes the migration of HER2-positive breast cancer cells and monocyte recruitment through CCL2-CCR2 signaling.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: July 01, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026